Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FDV49
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,610
Award facts
- Contract value 100% obligated
- $78,609.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $78,609.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens with a completion date of October 31, 2025. This non-set-aside competitive award was issued on October 30, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The supply of Dupixent, a specialty biologic medication, reflects the company's role in delivering specialized pharmaceuticals to military healthcare programs. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded without set-aside designations, and the company's contract portfolio demonstrates versatility in fulfilling federal medical supply needs through firm fixed-price delivery orders.
Quick answers
Who was awarded contract SPE2DB26FDV49?
SPE2DB26FDV49 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FDV49 worth?
The government has obligated $78,610 on SPE2DB26FDV49.
Is contract SPE2DB26FDV49 an order under another contract?
Yes. SPE2DB26FDV49 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDV49 competed?
The extent of competition for SPE2DB26FDV49 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award